The debate over access to addiction medications, particularly methadone treatment, is intensifying as private equity firms acquire stakes in methadone clinics. Calls for reform clash with the interests of these firms, leading to lobbying efforts to block easier access to the drug. Senator Ed Markey highlights the divide between physicians and business interests in this contentious issue.
The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform Part 3 from Lev Facher's War on Recovery https://t.co/pO4jteACkd
Private equity firms have ownership stakes in about a third of US methadone clinics & they are lobbying to block easier access to the drug. Sen. Ed Markey: “We have the physicians of America on our side, and they have the MBAs of America on their side."🔒 https://t.co/NLDsDynBdW
Part 3 of STAT's "War on Recovery" series by Lev Facher. The methadone clinic monopoly: Opioid treatment chains backed by private equity are fighting calls for reform Private equity firms have acquired stakes in nearly one-third of all methadone clinics in recent years,…
Private equity’s surging interest in the methadone treatment industry adds a new layer to the fraught and fast-shifting debate over access to addiction medications. https://t.co/zKdmmkk9q0
Methadone treatment in primary care settings offers a pathway to recovery for individuals battling opioid use disorder. Here’s why expanding access could save lives and combat the overdose crisis… https://t.co/WJp1fZHQYX #CatoHealth https://t.co/PB1jYSTPNB
It doesn't have to be this way. If we expanded treatment and created a full recovery system of care, things would be better. When are we all finally going to take care of our most vulnerable? @SteveAdami @TheWayOutSF @salvationarmysf https://t.co/buQV4skIIJ